News

The FDA has granted the first-ever approval for a diagnostic test alternative to Pap smear, the cobas HPV Test, despite objections from a number of organizations and healthcare providers.

Cancer patients felt more satisfied with their radiation treatment when they remained active in treatment decisions, according to a study conducted by researchers from the Perelman School of Medicine at the University of Pennsylvania.

No agents are recommended for the prevention of CIPN.

The FDA has approved ramucirumab (Cyramza) as a single-agent treatment for patients with unresectable or metastatic gastric cancer or gastroesophageal junction (GEJ) adenocarcinoma following fluoropyrimidine- or platinum-containing therapy.

The Cancer Support Community has a special resource for patients with every type of cancer to share their thoughts and concerns with others who are sharing similar experiences.

Imerman Angels was created on the belief that no one should have to face cancer alone.

After recently giving notice at the company where I have worked for almost 10 years, I was disturbed to hear about a comment made in passing by another manager.

The FDA has approved ofatumumab (Arzerra) plus chlorambucil for previously untreated patients with chronic lymphocytic leukemia (CLL) who are considered inappropriate for treatment with the chemotherapy fludarabine.

Adult survivors of childhood cancer face significant health problems as they age and are five times more likely than their siblings to develop new cancers, heart, and other serious health conditions beyond the age of 35 years

Benefits seen when intake is 7 or more servings per day.

The American Society of Clinical Oncology (ASCO) announced today three new evidence-based clinical practice guidelines on neuropathy, fatigue, and depression and anxiety in cancer survivors, the first three in a planned series of ASCO guidelines on survivorship care.

Patients who had a high Body Mass Index (BMI) before being diagnosed with colorectal cancer had an increased risk of death after diagnosis, even if their tumor harbored the microsatellite instability (MSI) marker

Women with irregular menstrual cycles have a 2.4-fold increased risk of death from ovarian cancer, according to a large, prospective study presented at the 2014 AACR Annual Meeting.

Continued monitoring of long-term effects of these drugs is warranted.

Palbociclib, an inhibitor of cyclin-dependent kinases (CDK) 4 and 6, more than doubled progression-free survival (PFS) when used in combination with letrozole for patients with estrogen receptor (ER)-positive, HER2-negative metastatic breast cancer

Women who took the fertility drugs clomiphene citrate (Clomid) or gonadotropins did not experience an increased risk for breast cancer compared with women who were not treated with those medications, according to a 30-year follow-up study published in the April issue of Cancer Epidemiology, Biomarkers & Prevention.

Study from one cancer center shows low knowledge and comfort levels.

Common nursing interventions are based solely on tradition, not on research or other evidence-based practice guidelines

Early-stage overweight endometrial and breast cancer survivors had moderate success in lowering their body mass index (BMI) and waste circumference after using the web and smart phone/tablet–based weight loss application "Lose It!"

A new study has found that one in four breast cancer survivors report that they are worse off financially even 4 years after their last treatment and 12% report they still have medical debt from their treatment.

Very few (1.3%) clinical cancer studies focus on people of non-white races.

Last fall, I started working with a couple of nursing colleagues on a project which involves LinkedIn training for oncology nurses. The number one concern voiced ahead of the training by roughly a quarter of those nurses . . . and hundreds more in my personal conversations over the last year?

For Amy Berman, BS, RN, today's cancer care delivery system is a lot like the sound of 1 hand clapping: It can be out of sync and unproductive, because it fails to touch the patients it treats.

Incidence and mortality has decreased 30% over past 10 years.

Study suggests that more than half of all patients received second and third line therapies.

International researchers from seven countries conducted a prospective study to determine risk reduction of ovarian, fallopian tube, or peritoneal cancer in women with a BRCA1 or BRCA2 mutation after oophorectomy and examine other factors, such as impact of this procedure on mortality and five year survival.

Second largest drugstore chain phasing our tobacco products by 10/1/14

The FDA has granted an accelerated approval to ibrutinib (Imbruvica) as a treatment for patients with chronic lymphocytic leukemia